ensun logo
Locations
Company type
Result types
Industries
Employees
Founding year
Datar Cancer Genetics Limited Logo

Datar Cancer Genetics Limited

We believe that relentless research, bold initiatives, sustained commitment and an unapologetic determination to succeed against cancer will help us defeat it. We dedicate ourselves to this singular mission as if our life depends on it. Cancer is a leading cause of death globally. Datar Cancer Genetics is a leader in developing blood-based diagnostics that can detect cancer early, offer non-invasive investigations for better treatment options, and track the progression of the disease or its recurrence. We believe that relentless research, bold initiatives, sustained commitment, and an unapologetic determination to succeed against cancer will help us defeat it. At the forefront of this revolution are our visionary scientists, who have devoted their expertise and ingenuity to craft unparalleled customized, non-invasive tests for the benefit of patients. Our groundbreaking tests serve as the key to unlocking the potential of molecularly targeted therapies, providing a profound understanding of tumor heterogeneity and dynamic tumor biology.

Quick overview

Nashik, India

51-100 Employees

Medium-Sized

Additional information

Working industry

Biotechnology

Type of company

Educational institution, Manufacturer

Ownership structure

Privately Held

Locations

1 Headquarter

Number of products

4 Products

Specialised areas

liquid biopsy, biopsy, pet ct scan, Oncology, Cancer, Cancers, Molecular Genetics, Genetics, Cancer Genetics, Biotechnology

Products & services of Datar Cancer Genetics Limited

Datar Cancer Genetics Limited offers a wide range of products and services

Product: Blood Based Cancer Solutions - Datar Cancer Genetics

Product

Blood Based Cancer Solutions - Datar Cancer Genetics

Go to product >

Product: Solutions - Datar Cancer Genetics

Product

Solutions - Datar Cancer Genetics

Go to product >

Product: Solutions_USA - Datar Cancer Genetics

Product

Solutions_USA - Datar Cancer Genetics

Go to product >

Product: Solutions_India - Datar Cancer Genetics

Product

Solutions_India - Datar Cancer Genetics

Go to product >

ESG score estimation

An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself

Country:

India


Overall risk estimation:

High


ESG country scores

The ESG Data of countries are based on public sources

Environment

E

Grade (A-E)

View details

Social

D

Grade (A-E)

View details

Governance

C

Grade (A-E)

View details

Headquarter of Datar Cancer Genetics Limited

Datar Cancer Genetics Limited operates in 1 country around the world

City: Nashik

State: Maharashtra

Country: India

Locations of Datar Cancer Genetics Limited

Get an overview of the locations of Datar Cancer Genetics Limited

Location

Country

State

City

Headquarter

India

Maharashtra

Nashik

Frequently asked questions (FAQ) about Datar Cancer Genetics Limited

Some frequent questions that have been asked about Datar Cancer Genetics Limited

The company headquarter of Datar Cancer Genetics Limited is located in Nashik, Maharashtra, India. It's worth noting, that the company may have more locations

As of the latest available information Datar Cancer Genetics Limited has around 51-100 employees worldwide.

The company Datar Cancer Genetics Limited has it's main focus in the industries of Biotechnology

Based on the founding year and the amount of employees the company Datar Cancer Genetics Limited seems to be a Medium-Sized at the current state. Note that over time that status can change

Competitors of Datar Cancer Genetics Limited

Check out some interesting alternative companies to Datar Cancer Genetics Limited

Universal Diagnostics's Logo

Universal Diagnostics

Seville, Spain

11-50 Employees

2012

We are driven forward by a vision of a future where cancer is curable. We are developing blood tests that detect cancer in its earliest stages so we can transform cancer into a disease that’s preventable and curable. We are applying our multi-omics, computational biology and machine learning approach to capture cancer’s signal for high-burden gastrointestinal cancers. Starting with colorectal cancer, we are building a multi-cancer platform that can identify the unique DNA regions associated with different types of cancers. Cancer’s early detection has become one of the greatest challenges of modern medicine, so we decided to team up with the best. Our company was founded on Silicon Valley’s ideals of technology and development (Singularity University), and we developed a network of world-class R&D partners including Quest Diagnostics and Hologic (Diagenode). Our Scientific Advisory Board includes leading oncologists, gastroenterologists and business experts from the US and Europe. We have built a network of >100 hospitals in the U.S.

RGCC's Logo

RGCC

Switzerland

51-100 Employees

2004

We are experts in developing and providing personalised cancer genetics tests for doctors and patients, and testing tumours for sensitivity and resistance to chemotherapy treatment and a range of natural substances. We encourage imaginative thinking to explore, question and reinvent, creating products, systems and technologies to challenge expectations. Working in the field of advanced medical genetics, our team of scientists and medical experts have developed a range of reliable tests so patients and clinicians can make informed decisions about healthcare. This is why we’re focused on creating modern and innovative products that will have a positive impact on day-to-day living.

DSRC Bengaluru's Logo

DSRC Bengaluru

Bengaluru, India

11-50 Employees

-

We are dedicated not only to treating the disease but also to nurturing the mind and spirit of our patients and their loved ones. We are committed to translating scientific breakthroughs into practical treatments that benefit cancer patients worldwide. Our mission is to continue pushing the boundaries of cancer research and treatment, providing hope and healing to cancer patients and their families across the globe. We dedicate all our services to uproot the fatal fear of cancer. Putting the patient at the center of everything we do is a fundamental belief that we hold, as we believe in a patient-first approach to medicine. Our team is dedicated to providing you with focused, patient-centric care and achieving the best outcomes possible, through treatment, counseling, a cancer-centric diet plan, and follow-up care. Research Centre is a pioneering institution in the field of cancer treatment, founded by two eminent scientists, Dr. We believe that the key to maintaining good health, preventing diseases, and fighting illnesses lies in the nutrient energy derived from natural foods.

DiaCarta's Logo

DiaCarta

Hayward, United States

11-50 Employees

2011

At DiaCarta, our mission is to improve the lives of cancer patients through innovative precision diagnostics. We are committed to providing accurate, reliable, and affordable diagnostics that help physicians make informed treatment decisions. Patient-Centric operations: Our mission is to provide innovative and affordable solutions for cancer patient management, and we prioritize the needs of patients and their families in everything we do. Innovation: We are committed to advancing precision diagnostics and improving patient outcomes through cutting-edge research and development. Continuous Improvement: We are dedicated to ongoing improvement and innovation, and we invest in the development of our team, our products, and our infrastructure to better serve our customers and achieve our mission. We are committed to designing and manufacturing products with the good of the patient in mind. DiaCarta’s RadTox™ Test to Monitor Tumor Response Receives Medicare Coverage. DiaCarta Announces Successful Completion of Oncuria® Validation Study with Nonagen Bioscience.

Prof. Dr. Med. Hans Bojar's Logo

Prof. Dr. Med. Hans Bojar

Dusseldorf, Germany

1-10 Employees

-

We deliver cancer diagnostics insights that provide doctors with precision treatment strategies that can provide better care to patients. We believe: Better diagnostics lead to better outcomes.

Teon Therapeutics's Logo

Teon Therapeutics

Temecula, United States

11-50 Employees

2017

We are on a relentless mission to push the boundaries of science in cancer care as we know it today. We are guided by the goal to ensure no patient with cancer ever hears the words, “there are no more options for you.”. We are guided by our shared experiences of serving patients with cancer, including our own cancer battles, those of our loved ones, and patients we’ve helped and served along the way. We are helping cancer patients spend time on what matters most by targeting untapped metabolic signaling pathways to restore anti-tumor immunity and provide better outcomes for patients. We are on a relentless mission to push the boundaries of science in cancer care as we know it. And we’re committed to developing and delivering important medicines to patients. Our highly accomplished leadership team is comprised of experts in tumor metabolism, cell signaling and GPCR therapeutic design. Targeting unexploited metabolic pathways backed by validated science and an initial focus on maximizing the potential benefits of GPCRs to address difficult-to-treat cancers.